PMC:7796052 / 6136-6331 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7796052","sourcedb":"PMC","sourceid":"7796052","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7796052","text":" partial agonist opens an opportunity for its repurposing as a therapeutic agent for the treatment of severe Covid-19.\n\n2. Results and Discussion\nIn order to have a preliminary insight into the a","divisions":[{"label":"title","span":{"begin":120,"end":145}}],"tracks":[{"project":"LitCovid-PubTator","denotations":[{"id":"183","span":{"begin":109,"end":117},"obj":"Disease"}],"attributes":[{"id":"A183","pred":"tao:has_database_id","subj":"183","obj":"MESH:C000657245"},{"subj":"183","pred":"source","obj":"LitCovid-PubTator"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}]},{"project":"LitCovid-sentences","denotations":[{"id":"T41","span":{"begin":120,"end":122},"obj":"Sentence"},{"id":"T42","span":{"begin":123,"end":145},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T41","pred":"source","obj":"LitCovid-sentences"},{"subj":"T42","pred":"source","obj":"LitCovid-sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PubTator","color":"#ecbe93","default":true},{"id":"LitCovid-sentences","color":"#a493ec"}]}]}}